S. 4303 · 117th Congress · Senate

Interchangeable Biologics Clarity Act

Active· Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709-2710)
Introduced
May 25, 22
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Interchangeable Biologics Clarity Act

This bill provides a statutory definition for first interchangeable biosimilar biological product and makes other technical changes with respect to the provisions that establish the corresponding periods of market exclusivity.

Action Timeline

2
  1. MAY 25, 2022•IntroReferral

    Introduced in Senate

  2. MAY 25, 2022•IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709-2710)

    2709Yea
    2710Nay
    0NV

Committees

1

Health, Education, Labor, and Pensions Committee

sshr00

Referred: May 25, 2022

Active